Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple numbing gel ease skin graft pain?

NCT ID NCT01999153

Symptom relief Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether applying the numbing medicine ropivacaine to a skin graft donor site can lower pain after surgery. 58 adults who needed a small skin graft were randomly assigned to get either ropivacaine or a saltwater solution on their wound dressing. The main goal was to see if ropivacaine reduced the need for painkillers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

58 people

The number who actually took part.

Started

Dec 2013

Finished

Oct 2018

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient older than 18 years old * Patient needing a thin skin graft \< 320 cm2 and which is possible on the thigh * Patient who read the information letter and signed the informed consent * Patient affiliated at a social security system * Effective contraceptive method for more than 3 months for women of childbearing age Exclusion Criteria: * Contraindication to one of the medicine used (allergy, intolerance, potential drug interaction) * Treatment by classII or III of analgesics or analgesic dose of aspirin(\>500mg per day) at the inclusion or randomization time * Preoperative EVA\>0 at the skin graft donor site on the thigh * Sensory disturbances of the lower limbs * Cognitive disturbances not allowing investigations * Pregnant or lactating women * People deprived of discernment * People deprived of their liberty by judicial or administrative authority * Protected adult (guardianship or trusteeship)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Graft pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Graft pain

Contacts and locations

Locations

  • UHRouen

    Rouen, 76031, France